More on NKTR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+26.6% Growth)
- Ratings (6.3 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nektar Therapeutics (NQ:NKTR)
Delayed: 60.98 +0.06 (0.10%)
Prev. Close $60.92  
Open$60.60 
52 Wk High$19.98 
52 Wk Low$10.52 
Day High$61.82 
Day Low$59.31 
P/E N/A  
EPS$-1.45 
Volume909,592 

Friends, Peers and Foes (?): LLY, ABBV, INCY, PFE, SNY (more...)

Jun 18, 2026 07:08 PM Form 4 NEKTAR THERAPEUTICS For: Jun 16 Filed by: ROBIN HOWARD W
Jun 17, 2026 07:13 PM Form 4 NEKTAR THERAPEUTICS For: Jun 15 Filed by: Zalevsky Jonathan
Jun 17, 2026 11:06 AM Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
Jun 16, 2026 11:07 AM Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
Jun 15, 2026 04:57 PM Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
Jun 5, 2026 04:31 PM Form 8-K NEKTAR THERAPEUTICS For: Jun 05
Jun 3, 2026 04:15 PM Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 27, 2026 06:16 PM Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
May 26, 2026 06:20 PM Form 3 NEKTAR THERAPEUTICS For: May 15 Filed by: Rubinstein Linda M
May 21, 2026 06:27 PM Form 4 NEKTAR THERAPEUTICS For: May 19 Filed by: Zalevsky Jonathan
View All Articles

Entities mentioned with NKTR

View All Entities